We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Hope on the Horizon for Chelsea’s NOH Drug
New Hope on the Horizon for Chelsea’s NOH Drug
February 21, 2013
Chelsea Therapeutics received good news on its blood pressure drug Northera, with the FDA saying it may have adequate data to support a resubmission of the drug.